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A B S T R A C T
Purpose: To examine the association between surgery delay and mortality in hip fracture patients with
and without known comorbidity.
Methods: We identified all patients with a first time hip fracture diagnose operated between January 1,
2010 and December 31, 2015 (n = 36,552). As a measure of comorbidity we used Charlson Comorbidity
Index stratified in categories: none (no registered comorbidities prior fracture), medium (1–2 points) and
high (3 points).
Results: No association between surgery delay, regardless of the threshold, and 30-days mortality was
observed among patients with high level of comorbidity. Surgery delay of >24h vs. 24 h was associated
with higher 0–30-days mortality in patients with medium level of comorbidity (adjusted HR: 1.12 (95%
CI: 1.01 ; 1.24)). In addition, surgery delay was associated with up to 45% increased mortality in patients
with none comorbidity prior surgery, although the confidence intervals were wide. Furthermore, surgery
delay of >24 h (vs. <24 h) and >48 h (vs. 48 h) was associated with higher 31–90-days mortality among
all patients (adjusted HR: 1.19 (95% CI: 1.10 ; 1.29) and 1.35 (95% CI: 1.16 ; 1.56), respectively), but in
particular among patients with none (adjusted HR: 1.26 (95% CI: 1.08 ; 1.47) and 1.65 (95% CI: 1.26 ; 2.17),
respectively) and medium (adjusted HR: 1.21 (95% CI: 1.07 ; 1.36) and 1.25 (95% CI: 1.00 ; 1.57),
respectively) level of comorbidity at the time of surgery.
Conclusions: There was an association between surgery delay and 30-days mortality in hip fracture
surgery patients with none and medium level of comorbidity, whereas no such association was observed
among hip fracture patients with a high comorbidity level. Surgery delay was associated with one year
increased risk of dying in both patients with and without comorbidity prior surgery.
© 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Mortality following hip fracture is very high. A meta-analysis,
based on studies from 1957 to 2009 showed that the all-cause
mortality in the first 3 months after hip fracture incidence was 6-
fold in women and 8-fold in men compared with the general
population [1]. Overall mortality within one year following hip
fracture is more than 30%, but highly dependent on the
comorbidity level before hip fracture [2].* Corresponding author at: Department of Clinical Epidemiology, Aarhus
University Hospital, Olof Palmes Alle 43-45, 8200 Aarhus N, Denmark.
E-mail address: bozt@clin.au.dk (B. Öztürk).
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0020-1383/© 2019 The Authors. Published by Elsevier Ltd. This is an open access article unA systematic review from 2010 showed that surgery delay was
associated with mortality up to one year after surgery [3]. The
optimal timing of surgery is a long-standing controversy and a
frequent clinical concern in the acute management of patients
with hip fracture [4]. Proponents of early treatment argue that
this approach minimizes the length of time a patient is confined
to bed rest, thereby reducing the risk for associated complica-
tions, such as pressure sores, deep vein thrombosis, and urinary
tract infections. Those favoring delaying surgery beyond the
guideline recommendations believe that this approach is required
to medically optimize patients, and therefore decrease the risk for
perioperative complications [5]. The lack of a broadly accepted
threshold for surgery delay illustrates that the controversy
remains. Previous studies have used different thresholds for
surgery delay, i.e., 12 [6,7], 24 [6,8] and 48 h [6] without clearder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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available data on the impact of comorbidity on the association
between surgical delay and subsequent mortality [7]. Only five
out of the 16 studies included in the systematic review presented
adjusted estimates of mortality [3], most commonly adjusted for
American Anesthetists Society score (a measure of a patient’s
fitness for surgery), age and sex. The role of comorbidity prior
surgery, measured with the presence of different medical
conditions, on the association between surgery delay and
mortality has so far not been examined in details, although it
is likely to be important [2]. It may be hypothesized that time
delays are less critical in hip fracture patients with comorbidities
as the delay can be used to ensure preoperative optimization. In
contrast, time delays may be more critical among hip fracture
patients without known comorbidity prior admission, who may
less likely to be offered preoperative optimization as they are
considered to be “healthy” patients. Hence, we aimed to
determine whether the association between surgery delay and
mortality differ between hip fracture patients with and without
known comorbidities. If increasing surgery delay is associated
with increasing mortality both in patients with and without
comorbidity, this would be an argument for further strengthening
the efforts to minimize surgery delay in all patients.
Thus, the aim of this study was to examine the association
between surgery delay and mortality in hip fracture patients with
and without comorbidities at the time of surgery.Fig. 1. Distribution of surgerMethods
Study design and setting
This study was a nationwide cohort study using prospective
collected data from Danish administrative and medical registers.
The Danish National Health Service provides tax-supported health
care for the entire Danish population [9].
Data sources
Patients were identified in the Danish Multidisciplinary Hip
Fracture Database (DMHFD) which is a nationwide population-
based clinical quality database established in 2003. The database
includes patients older than 65 years of age with a primary
diagnosis of hip fracture and a hip fracture operation in the same
hospitalization [10]. The DMHFD contains detailed clinical data
related to hip fracture treatment and quality of in-hospital care
indicators.
We used data from the Danish National Patient Registry (DNPR),
which is a population-based administrative registry. This database
holds data from all Danish hospitals since 1977 with complete
nationwide coverage since 1978. Information reported to DNPR
includes administrative data, diagnoses, treatments and exami-
nations related to hospitalizations, outpatient and emergency
room visits and data are updated continuously. Until 1993y delay among patients.
426 B. Öztürk et al. / Injury, Int. J. Care Injured 50 (2019) 424–431diagnoses were classified according to the International Classifi-
cation of Diseases, Revision 8 (ICD-8) and the ICD-10 thereafter [9].
Further, The Danish Civil Registration System (CRS) was used.
CRS is also an administrative register in Denmark established on
April 2, 1968, and contains individual-level information on all
persons residing in Denmark and daily updated information on
migration and vital status [11].
Finally, data from The Danish National Database of Reimbursed
Prescriptions (DNDRP) was used. DNDRP contains the reimburse-
ment records of all reimbursed drugs sold in community
pharmacies and hospital-based outpatient pharmacies in Denmark
since 2004 and covers the entire Danish population including
residents of long-term care institutions. DNDRP contains variables
such as pharmaceutical form, trade name, Anatomical Therapeutic
Chemical (ATC) Classification System code, and Defined Daily Dose
(DDD) of the medicinal product [12].
Data from the different data sources were linked together using
the Civil Personal Registration (CPR) number, which is a unique 10-
digit personal identification number. This number is the key
component of register linkage in Denmark, as it is used in all
Danish administrative and medical registers [11].
Study population
We identified all patients with a first time hip fracture diagnose
operated between January 1, 2010 and December 31, 2015
(n = 37,532). Patients with surgery delay of more than 72 h wereFig. 2. Proportion of deaths within 0–excluded as there was most likely an error in the registration of
either the time of admission or surgery. A total of 36,552 patients
were included in the final study population.
Surgery delay
Surgery delay was defined as the time (in hours) from hospital
admission to surgery. We defined five dichotomous variables: i)
delay more than 3 h ii) delay more than 6 h iii) delay more than 12 h
iv) delay more than 24 h and v) delay more than 48 h.
Mortality
As outcome, 0–30-days and 31–90-days all-cause mortality was
investigated. 0–30-days all-cause mortality was defined as death
within 30 days after surgery and 31–90-days all-cause mortality as
death within 90 days after surgery among patients who were alive
at day 31 after surgery. As supplementary analysis, 91–180-days
and 181–365-days all-cause mortality was also assessed.
Covariates
From the DMHFD following variables were included: sex, age
(65–74, 75–84, 85+ years), body mass index (BMI) (underweight:
0–18.5, normal: 18.5–25, overweight: 25+ kg/m2when categorized
according to the World Health Organisation [13]), type of fracture
(fracture of femoral neck, per-/sub-trochanter fractures), type of30-days and within 31–90-days.
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condition (care center, own home) and marital status (not married,
married). In addition, comorbidity history was included measured
by Charlson Comorbidity Index (CCI) (none: 0 point, medium: 1–2
points, high: >2 points) from the DNPR. Charlson Comorbidity
Index is an approach to classify patients with comorbid diseases
according to their risk of death from those diseases at the time of
enrollment into the study. The index contains 19 disease categories
each assigned score 1–6 according to strength of association with
one year mortality. It is a weighted index that takes into account
the number and for many diseases also the seriousness of the
comorbid diseases [14]. Furthermore, information about use of
anticoagulation drugs, psychiatric drugs, NSAIDs and steroids
(non-users and users) were included from the DNDRP. Users ofTable 1
Patient characteristics according to surgery delay.
Delay > 12 h Delay > 24
No Yes No 
N % N % N 
Total 7588 100 28964 100 23941 
Gender
Female 5327 70.2 20491 70.7 17061 
Male 2261 29.8 8473 29.3 6880 
Age category
65–74 1616 21.3 5761 19.9 4917 
75–84 2692 35.5 10698 36.9 8615 
85+ 3280 43.2 12505 43.2 10409 
BMI category
No data 1334 17.6 5213 18.0 4034 
Underweight (BMI < 18.5) 666 8.78 2450 8.46 2109 
Normal (18.5 < =BMI<25) 3595 47.4 13309 46.0 11208 
Overweight(25 < =BMI<30) 1993 26.3 7992 27.6 6590 
CCI category
None (0) 3026 39.9 11395 39.3 9688 
Medium (1–2) 3007 39.6 11714 40.4 9578 
High (3+) 1555 20.5 5855 20.2 4675 
Type of fracture
Fracture of femoral neck 3856 50.8 15764 54.4 12534 
Per and sub-trochanter fractures 3732 49.2 13200 45.6 11407 
Type of surgery
Osteosyntheses 5609 73.9 18609 64.2 16460 
Total and hemi hip arthroplasty 1979 26.1 10355 35.8 7481 
Housing condition
No data 773 10.2 3337 11.5 2447 
Care center 1361 17.9 4768 16.5 4049 
Own home 5454 71.9 20859 72.0 17445 
Marital status
Not married 5187 68.4 20294 70.1 16678 
Married 2401 31.6 8670 29.9 7263 
Anticoagulation drugs
Non-users 4836 63.7 17433 60.2 15054 
Users 2752 36.3 11531 39.8 8887 
Psychiatric drugs
Non-users 5214 68.7 20364 70.3 16724 
Users 2374 31.3 8600 29.7 7217 
NSAIDs
Non-users 6870 90.5 26146 90.3 21660 
Users 718 9.46 2818 9.73 2281 
Steroids
Non-users 7132 94.0 27287 94.2 22584 
Users 456 6.01 1677 5.79 1357 drugs were defined as patients with at least one date of redemption
365 days before surgery and non-users of drugs were patients
with no prescription within 365 days before hip fracture surgery.
All codes used in the study is provided in the electronic
Supplementary material, Table 1.
Statistics
We tabulated characteristics of the study population by
calculating proportions. Bivariate analysis of the explanatory
variables against the outcome was performed to identify the
variables to be used in the multivariable model. To evaluate the
association between surgerydelayand mortality, crude and adjusted
Hazard Ratios (HRs) were calculated using Cox proportional hazards h Delay > 48 h Total
Yes No Yes
% N % N % N % N %
100 12611 100 34438 100 2114 100 36552 100
71.3 8757 69.4 24386 70.8 1432 67.7 25818 70.6
28.7 3854 30.6 10052 29.2 682 32.3 10734 29.4
20.5 2460 19.5 6946 20.2 431 20.4 7377 20.2
36.0 4775 37.9 12579 36.5 811 38.4 13390 36.6
43.5 5376 42.6 14913 43.3 872 41.2 15785 43.2
16.8 2513 19.9 6093 17.7 454 21.5 6547 17.9
8.81 1007 7.99 2964 8.61 152 7.19 3116 8.52
46.8 5696 45.2 15986 46.4 918 43.4 16904 46.2
27.5 3395 26.9 9395 27.3 590 27.9 9985 27.3
40.5 4733 37.5 13676 39.7 745 35.2 14421 39.5
40.0 5143 40.8 13824 40.1 897 42.4 14721 40.3
19.5 2735 21.7 6938 20.1 472 22.3 7410 20.3
52.4 7086 56.2 18374 53.4 1246 58.9 19620 53.7
47.6 5525 43.8 16064 46.6 868 41.1 16932 46.3
68.8 7758 61.5 23035 66.9 1183 56.0 24218 66.3
31.2 4853 38.5 11403 33.1 931 44.0 12334 33.7
10.2 1663 13.2 3799 11.0 311 14.7 4110 11.2
16.9 2080 16.5 5827 16.9 302 14.3 6129 16.8
72.9 8868 70.3 24812 72.0 1501 71.0 26313 72.0
69.7 8803 69.8 24016 69.7 1465 69.3 25481 69.7
30.3 3808 30.2 10422 30.3 649 30.7 11071 30.3
62.9 7215 57.2 21138 61.4 1131 53.5 22269 60.9
37.1 5396 42.8 13300 38.6 983 46.5 14283 39.1
69.9 8854 70.2 24089 69.9 1489 70.4 25578 70.0
30.1 3757 29.8 10349 30.1 625 29.6 10974 30.0
90.5 11356 90.0 31122 90.4 1894 89.6 33016 90.3
9.53 1255 9.95 3316 9.63 220 10.4 3536 9.67
94.3 11835 93.8 32450 94.2 1969 93.1 34419 94.2
5.67 776 6.15 1988 5.77 145 6.86 2133 5.84
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of fracture, type of surgery, housing condition, maritalstatus, CCI, use
of anticoagulation drugs, psychiatric drugs, NSAIDs and steroids, and
calculated overall and stratified on CCI. Further, we stratified on
specific diseases included in the CCI. The assumption of proportional
hazards in the dataset were controlled visually by plotting log (cum
hazard) as a function of follow up time and found to be appropriate
[15]. All statistical analyses was performed with using of SAS 9.4
statistical software (SAS Institute Inc., Cary, USA).
Ethical approval
Study was approved by the Danish Data Protection Agency
(journal number 1-16-02-467-15).
Results
Population characteristics
The distribution of surgery delay among the patients is shown
in Fig. 1. A total of 7588 (20.76%) patients had a delay of maximum
12 h, 23,941 (65.50%) had a delay of maximum 24 h and 34,438
(94.22%) had a delay of maximum 48 h. Fig. 1 shows that the
majority of patients had a delay between 18–24 hours. Fig. 2 shows
the proportion of deaths within 0–30-days and within 31–90-days.
We observed some variation in mortality in relation to surgery
delay, without any clear association.Fig. 3. 0–30-days mortality.
* Adjusted for age, gender, BMI, type of fracture, type of surgery, housing condition, mariPatient characteristics according to surgery delay are shown in
Table 1. Comparing characteristics of the patients with surgery
delay 24 versus >24 h, we saw that the distribution of gender,
age, BMI, housing condition and marital status was similar in these
two groups. Compared to patients with surgery delay 24 h,
patients with surgery delay >24 h were slightly more comorbid,
had more fractures of femoral neck, total and hemi arthroplasty
procedures, and more patients had received anticoagulation drugs.
Similar findings regarding fracture type and surgery type were
observed for patients with surgery delay >12 versus 12 h and
those with surgery delay >48 versus 48 h.
Descriptive statistics on patients with surgery delay more than
3 h vs less than 3 h and more than 6 h vs less than 6 h are shown in
the electronic Supplementary material, Table 2.
0–30-days mortality
The absolute mortality risk and corresponding adjusted HRs
with 95% CIs are presented in Fig. 3. Overall absolute mortality
risks were between 10.3% and 12.0% depending on the surgery
delay. The adjusted HR for 0-30-days mortality varied from 0.87
(95% CI: 0.72 ; 1.06) for patients with surgery delay over 3 h
compared with patients with delay less than 3 h to 1.07 (95% CI:
1.00 ; 1.14) for patients having more than 24 h surgery delay
compared with patients with surgery delay 24 h. Thus, we
observed no clear threshold for surgery delay indicating increased
mortality when looking into entire study population.tal status, CCI, use of anticoagulation drugs, psychiatric drugs, NSAIDs and steroids.
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mortality risks increased with increasing comorbidity level irrespec-
tive of surgery delay. Our stratified analyses suggest no association
between surgerydelayand mortalityamong hip fracture patientswith
high comorbidity. However, patients with a medium level of
comorbidity having more than 24 h surgery delay had increased 0–
30-days mortality compared with patients having less than 24 h
surgery delay (adjusted HR: 1.12 (95% CI: 1.01 ; 1.24)). In addition, our
stratified analyses suggest that surgery delay might be associated with
an increased mortality in patients with none comorbidity prior
surgery, although the confidence intervals were wide.
31–90-days mortality
Overall absolute mortality risks 31–90-days after surgery were
between 7.4% and 8.1% depending on the surgery delay (Fig. 4). In
the overall analysis, patients having more than 24 h surgery delay
had an increased adjusted HR of death within 31–90-days of 1.19
(95% CI: 1.10 ; 1.29) compared with patients having 24 h surgery
delay. Furthermore, patients with a surgery delay of more than 48 h
had an adjusted HR for death of 1.35 (95% CI: 1.16 ; 1.56) compared
with patients with surgery delay of less than 48 h.
Similar associations for the thresholds of 24 and 48 h were
observed among patients with none and medium comorbidity
level. Thus, there were increased adjusted HRs when patients had
more than 24 or 48 h delay, for patients with none comorbidity
prior surgery (adjusted HR: 1.26 (95% CI: 1.08 ; 1.47) and 1.65 (95%
CI: 1.26 ; 2.17), respectively) and for patients with medium level ofFig. 4. 31–90-days mortality.
* Adjusted for age, gender, BMI, type of fracture, type of surgery, housing condition, maricomorbidity (adjusted HR: 1.21 (95% CI: 1.07 ; 1.36) and 1.25 (95%
CI: 1.00 ; 1.57) respectively). In addition, there was an association
between surgery delay and mortality for patients with high level of
comorbidity (adjusted HR: 1.10 (95% CI: 0.95 ; 1.28)) in patients
with surgery delay >24 vs.  24 h and 1.21 (95% CI: 0.91 ; 1.59) in
patients with surgery delay >48 vs.  48 h), although the confi-
dence intervals were wide.
91–180-days and 181–365-days mortality
In the electronic Supplementary material, Figs. 1 and 2 the
analysis investigating 91–180-days and 181–365-days overall and
stratified mortality are shown. The results are mainly in consistent
with the result for 31–90-days mortality.
Surgery delay and mortality according to specific comorbidities
The association between surgery delay and mortality stratified
on various disease groups was examined for the threshold of 24 h
(Fig. 5). We observed no association between surgery delay and 30-
days mortality for patients with individual comorbidities prior
surgery. Surgery delay >24 vs 24 h was associated with increased
30-days mortality among patients having ulcer disease (adjusted
HR: 1.44 (95% CI: 1.12 ; 1.86). When 31–90-days mortality was
examined, a significant difference between the two groups was
present for CPD and renal disease. Patients with CPD having a
surgery delay more than 24 h had an adjusted HR of 1.26 (95% CI
1.04 ; 1.54) for 31–90-days mortality than patients with a surgerytal status, CCI, use of anticoagulation drugs, psychiatric drugs, NSAIDs and steroids.
Fig. 5. Delay of >24 vs 24 h according to specific comorbidities**.
* Adjusted for age, gender, BMI, type of fracture, type of surgery, housing condition, marital status, use of anticoagulation drugs, psychiatric drugs, NSAIDs, steroids and the
comorbidity groups in CCI expect for the stratified group. ** Hemiplegia and AIDS are not presented due to few observations. *** Cancer including any tumor, leukemia,
lymphoma, metastatic solid tumor. **** Chronic pulmonary disease. ***** Connective tissue disease. ****** Cardiovascular disease including myocardial infarction, congestive
heart failure, peripheral vascular disease and cerebrovascular disease.
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more than 24 h had an adjusted HR of 1.69 (95% CI 1.23 ; 2.31) for
31–90-days mortality than patients with a surgery delay 24 h.
Discussion
In this nationwide cohort study of 36,552 hip fracture patients
we found for the first time an association between surgery delay
and 30-days mortality in hip fracture surgery patients with none
and medium level of comorbidity, whereas no such association was
observed among hip fracture patients with high comorbidity level.
In addition, surgery delay is associated with one year increased risk
of dying in both patients with and without comorbidity prior
surgery.
Strength and limitations
The strengths of this study include the use of prospectively
collected data from national public registers and databases
characterized by a high data validity [9,11,16], as well as complete
follow up of all patients. In addition, we were able to control and
stratify for a wide range of covariates that may potentially have an
impact on the association between surgery delay and mortality and
the recent study period (2010–2015) means that the study findings
reflect current clinical practice, including very recent of current
surgical and anesthetic techniques, devices and clinical guidelines.The primary limitation was the risk of residual or unaccounted
confounding as is often the case in observational studies. Hence,
we lacked data on socioeconomic factors and life-style factors such
as alcohol and smoking, which could at least in theory confound
the association between surgery delay and mortality. In addition,
misclassification of comorbidity may have occurred, e.g. due to lack
of data on psychiatric diseases and severity of some diseases such
as diabetes and kidney failure. We did not have information on the
specific reasons for surgery delay, however, it is probably likely to
be medical for many patients with high comorbidity, and due to
lack of surgical capacity for the majority of patients with no
comorbidity prior to surgery.
Comparison with previous literature and possible explanations of our
finding
Until now, several studies have investigated the association
between surgery delay and mortality, but no studies, to our
knowledge, investigated the association between surgery delay
and mortality stratified on comorbidity, which is what distinguish
this study from other studies. By this, our study gives a different
perspective to the discussion about surgery delay. Further, most
studies failed to adjust for factors as comorbidity, BMI and drug
use, while we adjust for those in our study. This can be an
explanation of why Nyholm et al. shows a significant association at
the 12-, 24- and 48 h threshold on 0–30-days mortality [8] and
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surgery delay and 0–30-days mortality, while we in our study find
a borderline significant association at the 24 h threshold on the 0–
30-days mortality. This suggest, that these variables have a
substantial impact when investigating the association between
surgery delay and mortality. Previous studies are also using older
data, than the data we use in this study, thus they may not include
patients treated according to current clinical guidelines. The
difference between the results from former studies and this study
can also suggest that the preoperative optimization and treatment
for hip fracture patients have changed since then.
That patients with none/medium level of comorbidity are more
effected of surgery delay than patients with high level of
comorbidity may seem as a surprising founding. One explanation
for this could be that sicker patients may benefit from a delay in
order to optimize their medical condition while there is no
theoretical benefit for healthier patients to wait for surgery. Rather,
for the healthy patients there is the potential for increased
complications and poor outcome [5].
A common reason for operative delay include the lack of
surgical capacity at the operating room and/or surgical personnel
[5]. Selection of patients for delay might not be correct. Given that
high comorbidity patients are delayed due to medical reasons they
will receive medical optimization. Patients without comorbidity
might be more often selected to wait for surgery because these are
considered to be “healthy” and can wait. A fundamental
misunderstanding may lead to the assumption that healthy
patients will not be harmed if they are delayed, because they
are healthy. Our study suggest, that such understanding is basically
not true for hip fracture patients and it shows that there is no harm
for sick patients to be meaningfully delayed while healthy patients
may be harmed by a delay. In a review of available literature Lewis
et al. suggest a similar understanding. They suggest that an early
surgery is appropriate in the relatively fit patient (ASA 1 or 2) with
a fracture of the hip, probably within 12 h to 48 h. However,
patients with an ASA score of 3 or 4 should allow surgery to be
delayed to allow the general condition of the patient to be
improved and this decision should not be classed as a fault in
management [17]. Hip fracture patients are defined as healthy in
our study if they did not have hospital contact for any of the 19
diagnoses included in the CCI and recorded in the DNPR. However,
these patients are in general considered to be frail, functionally
dependent, have a high prevalence of cognitive impairment, and
could have underlying conditions such as dehydration, low kidney
function, inflammation which does not necessary require hospital
contact and is thus difficult to account with data from the DNPR.
Further, patients with known comorbidity often receive organized
help at home from nurses, which is not the case for the healthy
patients. While waiting for help at home to be organized after
discharge, they medical condition deteriorate increasing the risk of
dying. Hypothetical, an un-constructive use of the delay in the less
vulnerable patients, compared to patients with a known high
comorbidity burden at the time of surgery, could lead to an
association between delay in surgery and mortality in the less
vulnerable patients both in short- and long-term period after
surgery.
Clinical implications
The study indicates, that clinicians at the hospital have to
continuously target treatment to not only patients with high level
of comorbidity, but also hip fracture patients without known
comorbidity prior surgery.Conclusion
There was an association between surgery delay and 30-days
mortality in hip fracture surgery patients with none and medium
level of comorbidity, whereas no such association was observed
among hip fracture patients with high comorbidity level. Surgery
delay is associated with one year increased risk of dying in both
patients with and without comorbidity prior surgery.
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